Bringing healthcare closer to where people live, work and shop can effectively tackle hypertension – the most deadly noncommunicable disease.

Novartis and Broad Institute researchers explore how gut bacteria contribute to health and disease, beginning with type 1 diabetes.

A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.

Read a patient’s perspective on living with a rare, life-threatening blood cancer called myelofibrosis and why it’s important to rally the community.

To showcase how people living with ITP triumph and persevere, Novartis partnered with photographer Kate T. Parker on a series of photo essays.

Novartis team perseveres to develop more personalized approach to breast cancer therapy.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Novartis investigators find genetic explanations for why some young patients relapse.

Combination of two compounds shows promise in the lab

Novartis researchers are working to extend the life of organ transplants